| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
| filingDate |
1997-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1998-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c555f128031e55cf7d83f6c2ed7a0f8 |
| publicationDate |
1998-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5786451-A |
| titleOfInvention |
23 Kd human retinal CAR antigen |
| abstract |
A purified polypeptide having an amino acid sequence SEQ ID NO: 1, which is a human retinal cancer-associated retinopathy antigen capable of selectively binding to antibodies present in a body fluid of a human patient afflicted with cancer associated retinopathy. A recombinant 23 kDa polypeptide which is recombinantly synthesized human retinal cancer-associated retinopathy antigen having an amino acid sequence SEQ ID NO: 1. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8313917-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009088460-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009088460-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7556938-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8445220-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010284923-A1 |
| priorityDate |
1992-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |